Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. But some researchers are wary about this going too far.
from NYT > Health https://ift.tt/2REshAG
May 09, 2021
Rose
Health - The New York Times, NYT > Health
No comments
Related Posts:
Health Officials Advise White House to Scale Back Booster Plan for NowFederal regulators warned on Thursday they may not have enough data to recommend boosters for anyone except certain recipients of the Pfizer vaccine by late September. from NYT > Health https://ift.tt/3BD3PRZ … Read More
Abortion Arrives at the Center of the American Political MaelstromThe Supreme Court’s decision not to block a Texas law banning most abortions left Republicans eager to replicate it. Democrats reeled, but sensed a winning issue in coming elections. from NYT > Health https://ift.tt/3BDTk… Read More
Hospitalizations for Children Sharply Increase as Delta SurgesVaccinations, however, have made a difference. from NYT > Health https://ift.tt/3n4VvX4 … Read More
What to Know: Purdue Pharma SettlementThe maker of OxyContin won bankruptcy approval on Sept. 1 as part of a far-ranging settlement that ended thousands of lawsuits against the company and its owners, the Sacklers. from NYT > Health https://ift.tt/3BEtcCP … Read More
New Zealand Is Under Lockdown to Contain Delta's SpreadThe country is holding fast to a lockdown to contain an outbreak that began in mid-August. But it’s also acknowledging that lockdowns can’t go on forever. from NYT > Health https://ift.tt/3zAF0pc … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment